The law of mass action applied to neurodegenerative disease: A hypothesis concerning the etiology and pathogenesis of complex diseases

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 1, 2004, Pages

  Singleton, Andrew ^a   Myers, Amanda ^a   Hardy, John ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 2; PRION PROTEIN; PROTEINASE; TAU PROTEIN;

AMINO ACID SEQUENCE; AUTOSOMAL DOMINANT INHERITANCE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HAPLOTYPE; HUMAN; HYPOTHESIS; MASS ACTION; PARKINSON DISEASE; PATHOGENESIS; PREDICTION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVIEW; SEQUENCE ANALYSIS; TISSUE DISTRIBUTION; TRISOMY 21;

HAPLOTYPES; HUMANS; MODELS, GENETIC; NEURODEGENERATIVE DISEASES;

EID: 1842507639     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Owen, F., Poulter, M., Lofthouse, R., Collinge, J., Crow, T.J., Risby, D., Baker, H.F., Ridley, R.M., Hsiao, K. and Prusiner, S.B. (1989) Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet, 1, 51-52.
2. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover A. et al. (1998) Coding and splice donor site mutations in tau cause autosomal dominant dementia (FTDP-17). Nature, 393, 702-705.
3. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the a-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
4. Rogaeva, E. (2002) The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. Neuromol. Med., 2, 1-10.
5. Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G. and Iwatsubo, T. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature, 422, 438-441.
6. Edbauer, D., Winkler E., Regula, J.T., Pesold, B., Steiner, H. and Haass, C. (2003) Reconstitution of gamma-secretase activity. Nat. Cell Biol., 5, 486-488.
7. Hardy, J. and Gwinn-Hardy, K. (1998) Genetic classification of primary neurodegenerative disease. Science, 282, 1075-1079.
8. Klein, W.L. (2002) ADDLs and protofibrils-the missing links? Neurobiol. Aging, 23, 231-235.
9. Palmer, M.S., Dryden, A.J., Hughes, J.T. and Collinge, J. (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt Jakob disease. Nature, 352, 340-342.
10. Collinge, J., Palmer, M.S. and Dryden, A.J. (1991) Genetic predisposition to iatrogenic Creutzfeldt Jakob disease. Lancet, 337, 1441-1442.
11. Mead, S., Mahal, S.P., Beck, J., Campbell, T., Farrall, M., Fisher, E. and Collinge, J. (2001) Sporadic but not variant Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am. J. Hum. Genet., 69, 1225-1235.
12. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P., Aguet, M. and Weissmann C. (1993) Mice devoid of PrP are resistant to scrapie. Cell, 73, 1339-1347.
13. Liddell, M.B., Bayer, A.J. and Owen, M.J. (1995) No evidence that common allelic variation in the amyloid precursor protein (APP) gene confers susceptibility to Alzheimer's disease. Hum. Mol. Genet., 4, 853-858.
14. Wavrant-De Vrieze, F., Crook, R., Holmans, P., Kehoe, P., Owen, M.J., Williams, J., Roehl, K., Lahiri, D.K., Shears, S., Booth, J. et al. (1999) Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late onset Alzheimer's disease. Neurosci. Lett., 269, 67-70.
15. Olson, J.M., Goddard, K.A. and Dudek, D.M. (2001) The amyloid precursor protein locus and very-late-onset Alzheimer disease. Am. J. Hum. Genet., 69, 895-899.
16. Olson, M.I. and Shaw, C.M. (1969) Presenile dementia and Alzheimer's disease in mongolism. Brain, 92, 147-156.
17. Prasher, V.P., Farrer, M.J., Kessling, A.M., Fisher, E.M., West, R.J., Barber, P.C. and Butler, A.C. (1998) Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann. Neurol., 43, 380-383.
18. Spillantini, M.G. and Goedert, M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci., 21, 428-433.
19. Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Pérez-Tur, J., Hardy, J., Lynch, T., Bigio, E. and Hutton, M. (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet., 4, 711-715.
20. Houlden, H., Baker, M., Morris, H.R., MacDonald, N., Pickering-Brown, S., Adamson, J., Lees, A.J., Rossor, M.N., Quinn, N.P., Kertesz, A. et al. (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology, 56, 1702-1706.
21. Togo, T., Sahara, N., Yen, S.H., Cookson, N., Ishizawa, T., Hutton, M., de Silva, R., Lees, A. and Dickson, D.W. (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J. Neuropathol. Exp. Neurol., 61, 547-556.
22. Morris, H.R., Baker, M., Yasojima, K., Houlden, H., Khan, M.N., Wood, N.W., Hardy, J., Grossman, M., Trojanowski, J., Revesz, T. et al. (2002) Analysis of tau haplotypes in Pick's disease. Neurology, 59, 443-445.
23. Pérez-Tur, J., Buee, L., Morris, H.R., Waring, S.C., Onstead, L., Wavrant, De Vrieze, F., Crook, R., Buee-Scherrer, V., Hof, P.R., Petersen, R.C. et al. (1999) Neurodegenerative diseases of Guam: analysis of tau. Neurology, 53, 411-413.
24. Hutton, M. (2000) 'Missing' tau mutation identified. Ann. Neurol., 47, 417-418.
25. Spillantini, M.G. and Goedert, M. (2000) The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann. NY Acad. Sci., 920, 16-27.
26. Kruger, R., Vieira-Saecker, A.M., Kuhn, W., Berg, D., Muller, T., Kuhnl, N., Fuchs, G.A., Storch, A., Hungs, M., Woitalla, D. et al. (1999) Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/apolipoprotein E genotype. Ann. Neurol., 45, 611-617.
27. Farrer, M., Maraganore, D.M., Lockhart, P., Singleton, A., Lesnick, T.G., de Andrade, M., West, A., de Silva, R., Hardy, J. and Hernandez, D. (2001) α-Synuclein gene haplotypes are associated with Parkinson's disease. Hum. Mol. Genet., 10, 1847-1851.
28. Chiba-Falek, O., Touchman, J.W. and Nussbaum, R.L. (2003) Functional analysis of intra-allelic variation at NACP-Rep1 in the α-synuclein gene. Hum. Genet., 113, 426-431.
29. Singleton, A., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841.
30. Farrer, M., Wang, D., Lincoln, S., Kachergus, J., Langston, W.J. and Dickson, D. (2003) Genomic multiplication of the alpha-synuclein gene in three kindreds with familial Lewy body disease. American Society of Human Genetics. Abstract 2227.
31. El-Agnaf, O.M., Salem, S.A., Paleologou, K.E., Cooper, L.J., Fullwood, N.J., Gibson, M.J., Curran, M.D., Court, J.A., Mann, D.M., Ikeda S. et al. (2003) α-Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J., 17, 1945-1947.
32. Hoogendoorn, B., Coleman, S.L., Guy, C.A., Smith, K., Bowen, T., Buckland, P.R. and O'Donovan, M.C. (2003) Functional analysis of human promoter polymorphisms. Hum. Mol. Genet., 12, 2249-2254.
33. Lambert, J.C., Pérez-Tur, J., Dupire, M.J., Galasko, D., Mann, D., Amouyel, P., Hardy, J., Delacourte, A. and Chartier-Harlin, M.C. (1997) Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum. Mol. Genet., 6, 2151-2154.
34. Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B. and Kinzler, K.W. (2002) Allelic variation in human gene expression. Science, 297, 1143.
35. Farrer, L.A., Cupples, L.A., Wiater, P., Conneally, P.M., Gusella, J.F. and Myers, R.H. (1993) The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD. Am. J. Hum. Genet., 53, 125-130.
36. Shtilerman, M.D., Ding, T.T. and Lansbury, P.T. Jr (2003) Molecular crowding accelerates fibrillization of α-synuclein: Could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry, 41, 3855-3860.